A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight ManagementF. Xavier Pi‐Sunyer, John Wilding, Christine B. Jensen et al.|New England Journal of Medicine|2015Cited by 2.6k
Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trialFrank L. Greenway, Eduardo Dunayevich, Ken Fujioka et al.|The Lancet|2010Cited by 1k
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trialCarel W. le Roux, Aila Rissanen, Arne Astrup et al.|The Lancet|2017Cited by 843
Effects of Naltrexone Sustained- Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients With Type 2 DiabetesPriscilla Hollander, Alok Gupta, Raymond A Plodkowski et al.|Diabetes Care|2013Cited by 494
The relationship between early weight loss and weight loss at 1 year with naltrexone ER/bupropion ER combination therapyKen Fujioka, Frank L. Greenway, Raymond A Plodkowski et al.|International Journal of Obesity|2016Cited by 85